Axcynsis Therapeutics
PrivateLast Round
VC Round
Oct 1, 2024
Total Funding Raised
$15M
Momentum Score
25 /100
Company Overview
Axcynsis Therapeutics is a biotechnology company that develops antibody-drug conjugate (ADC) therapies designed for treating cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axcynsis Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Axcynsis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 1, 2024 | ||||
| Seed | May 4, 2022 |
Axcynsis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Trinity Innovation Fund | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 188% MoM, reaching 916.
- Apr 21, 2025
Developing new Antibody Drug Conjugate (ADC) therapies.
Axcynsis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axcynsis Therapeutics's valuation, stock price, and market status.
